Eli Lilly and Company · LLY · Next earnings

Eli Lilly and Company reports Wednesday, Feb 3, 2027

LLY reports before market open with consensus EPS at $11.16 and revenue at $24.51B. Last quarter: Lilly raises 2026 guidance as incretin growth and pipeline progress continue

Reports Before market open91 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $11.16 Calendar consensus
Consensus revenue $24.51B Calendar consensus
Report date Feb 3, 2027 Wednesday, date estimated
Session Before market open 91 days away

Where LLY left off: FY2026 Q3

Full report

Lilly raises 2026 guidance as incretin growth and pipeline progress continue

EPS surprise +31.7% Reported $7.48 vs $5.68
Revenue surprise +8.0% Reported $24.40B vs $22.58B
Stock move +6.6% Event window
Subsequent drift 0.0% Up to 20 sessions

Management raised full-year 2026 revenue guidance to $91-$92 billion and non-GAAP EPS guidance to $35-$36.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Potential U.S. net price pressure on GLP-1 products.
  • Regulatory and reimbursement uncertainty for Foundayo.
  • Reliance on the Medicare GLP-1 Bridge program and possible policy changes.
  • Intensifying competition from Wegovy and oral GLP-1 agents.

Questions analysts left open

  • Whether guidance upside reflects unit growth or price declines.
  • Real-world persistence of tirzepatide and other GLP-1 agents.
  • Competition from Wegovy and upcoming oral GLP-1 products.
  • Sustainability of the Medicare GLP-1 Bridge program and coverage policy.

Ask FN2 about LLY next report

Transcript, numbers and history already loaded
What should I watch for in LLY's next earnings report?How did LLY guide last quarter, and is consensus above or below that?Give me the bull and bear case going into LLY earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the LLY recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent LLY quarters

All LLY earnings
+6.6%FY2026 Q3+4.9%FY2026 Q2+9.8%FY2026 Q1+10.3%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.